Company intelligence / Profile preview

Magellan Rx Management

Phoenix, Arizona, United Statesweb.primetherapeutics.com ↗

Ownership: Private
Employees: ~257
Development stage: Other

Overview

Magellan Rx Management was a leading pharmacy benefit manager specializing in specialty drug management and comprehensive PBM services for commercial and government markets. It played a significant role in biosimilar adoption and cost containment strategies for health plans. In December 2022, it was acquired by Prime Therapeutics for $1.35 billion and now operates under the Prime Therapeutics brand.

Industry: Non-Academic Healthcare

Partnerships

No specific major pharmaceutical/biotech partnerships disclosed; works with health plans, employers, state governments

Beyond the preview

Go deeper on Magellan Rx Management.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Magellan Rx Management.

Explore the full profile